International society of liquid biopsy (ISLB) perspective on minimal requirements for ctDNA testing in solid tumors

Through the work of its Quality Control and Accreditation Committee, ISLB has brought together an international panel of experts to define consensus-based minimal requirements for ctDNA testing. This initiative addresses critical aspects across all testing phases —pre-analytical, analytical, and post-analytical— and represents the first global framework for quality assurance in liquid biopsy. EMQN was part of this panel.